# Erythropoietic protoporphyria linked to intricate double heterozygous mutations in theFECH gene: a case report and literature review

**Authors:** Hongli Xiong, Song He, Zhaoxia Yang, Ruizao Zheng, Huihong Yu

PMC · DOI: 10.1186/s13023-025-03860-8 · Orphanet Journal of Rare Diseases · 2025-07-02

## TL;DR

A teenager with a rare genetic disorder called erythropoietic protoporphyria (EPP) developed severe liver complications and died, highlighting the importance of considering EPP in cases of unexplained liver dysfunction.

## Contribution

The paper reports a novel FECH gene mutation (c.763G > T, exon 7) in a patient with EPP.

## Key findings

- The patient had a complex heterozygous mutation in the FECH gene, leading to EPP diagnosis.
- Liver complications were the primary clinical manifestation in this case of EPP.
- A literature review found a 4.1% mortality rate among 98 EPP cases over the past decade.

## Abstract

Erythropoietic protoporphyria is an inherited disorder characterized by mutations in the FECH gene, which encodes the enzyme ferrous chelatase. These mutations disrupt normal heme synthesis, leading to the accumulation of protoporphyrin in erythrocytes and other tissues. Clinical manifestations include cutaneous photosensitivity, characterized by burning and itching of the skin, and, less commonly, liver failure.

A teenager presented with abdominal pain, distention, and jaundice, along with a history of suspected photosensitivity. Lab tests revealed abnormal liver enzymes. Imaging showed liver cirrhosis. Liver biopsy confirmed bile accumulation and protoporphyrin deposits. Genetic testing identified a complex heterozygous mutation in the FECH gene, leading to a diagnosis of EPP.

The patient ultimately succumbed to complications arising from decompensated cirrhosis, specifically ruptured esophagogastric fundal varices and hepatorenal syndrome. We retrospectively reviewed 98 cases of EPP reported in English literature over the past decade (2014–2024). The overall mortality rate was 4.1% (4 patients).

Patients diagnosed with EPP may exhibit hepatic dysfunction as their primary clinical manifestation. In the evaluation of the etiology of liver dysfunction, EPP, a rare genetic disorder, should be considered. This case report describes a novel mutation in the FECH gene located at chr18-55226418 (c.763G > T, exon 7), thereby contributing to the expanding spectrum of known FECH gene mutations.

## Linked entities

- **Genes:** FECH (ferrochelatase) [NCBI Gene 2235]
- **Diseases:** erythropoietic protoporphyria (MONDO:0001676), liver failure (MONDO:0100192), hepatorenal syndrome (MONDO:0001382), cirrhosis (MONDO:0005155)

## Full-text entities

- **Genes:** FECH (ferrochelatase) [NCBI Gene 2235] {aka EPP, EPP1, FCE}
- **Diseases:** hepatic dysfunction (MESH:D008107), hepatorenal syndrome (MESH:D006530), liver cirrhosis (MESH:D008103), jaundice (MESH:D007565), cirrhosis (MESH:D005355), liver dysfunction (MESH:D017093), abnormal liver enzymes (MESH:D056486), esophagogastric fundal varices (MESH:D014648), itching (MESH:D011537), genetic disorder (MESH:D030342), EPP (MESH:D046351), abdominal pain (MESH:D015746)
- **Chemicals:** heme (MESH:D006418), protoporphyrin (MESH:C028025)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** c.763G > T

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12224708/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12224708/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12224708/full.md

---
Source: https://tomesphere.com/paper/PMC12224708